Detection of cerebral microembolic signals by transcranial Doppler may be a useful part of the equation in determining stroke risk in patients with antiphospholipid antibody syndrome

Abstract

Get full access to this article

View all access options for this article.

References

Hughes Grv. Thrombosis, abortion, cerebral disease and the lupus anticoagulant. Br Med J 1983; 287: 1088-1091.

Gharavi AE , Harris EN , Asherson RA , Hughes Grv. Antiphospholipid antibodies: isotype distribution and phospholipid specificity . Ann Rheum Dis 1987; 46: 1-6.

Triplett DA , Brandt JT , Musgrave KA , Orr CA The relationship between lupus anticoagulants and antibodies to phospholipids . JAMA 1988; 259: 550-554.

McNeil HP , Simpson RJ , Chesterman CN , Krilis SA Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: beta2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4124.

Galli M. et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990 ; 335: 1544-1547.

Matsuura E. et al. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336: 177-178 (letter).

Kandiah DA , Sheng YH , Krilis SA β2-Glycoprotein I: Target antigen for autoantibodies in the 'antiphospholipid syndrome'. Lupus 1996; 5: 381-385.

Hunt JE et al. A phospholipid-β2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1992; 1: 75-81.

Oosting JD et al. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? Blood 1993; 81: 2618-2625.

10.

Cabral AR , Cabiedes J. , Alarcon-Segovia D. Antibodies to phospholipid-free β2-glycoprotein-I in patients with primary antiphospholipid syndrome. J Rheumatol 1995; 22: 1894-1898.

11.

Viard JP , Amoura Z. , Bach JF Association of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992;93: 181-186.

12.

Cabiedes J. , Cabral AR , Alarcon-Segovia D. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-β2-glycoprotein-I than with antiphospholipid antibodies. J Rheumatol 1995 ; 22: 1899-1906.

13.

Horbach DA , Derksen Rhwm , de Groot PG The presence of anti-β2glycoprotein I and anti-prothrombin antibodies and their correlations with venous and arterial thrombosis. Ann Med Intern 1996; 147 (Suppl. I): 42-43.

14.

Koike T. , Matsuura E. Anti-β2-glycoprotein I antibody: specificity and clinical significance . Lupus 1996; 5: 378-380.

15.

Piette JC 1996 Diagnostic and classification criteria for the antiphospholipid/cofactors syndrome: a 'mission impossible'? Lupus 1996 ; 5: 354-363.

16.

Alarcon-Segovia D. et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989 ; 68: 353-365.

17.

Escalante A. , Brey RL , Mitchell BD Jr , Dreiner U. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus . Am J Med 1995; 98: 559-565.

18.

Antiphospholipid Antibodies in Stroke Study (APASS) Group. Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. Neurology 1993; 43: 2069-2073.

19.

Camerligo M. et al. Anticardiolipin antibodies in acute nonhemorrhagic stroke seen within six hours after onset. Acta Neurol Scand 1995; 92: 60-71.

20.

Brey RL , Hart RG , Sherman DG , Tegeler C. Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990; 40: 1190-1196.

21.

Levine SR , Deegan MJ , Futrell N. , Welch Kma. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 1990; 40: 1181-1189.

22.

The Antiphospholipid Antibodies and Stroke Study Group (APASS). Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death. Neurology 1997; 48: 91-94.

23.

Rosove MH , Brewer Pmc. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992; 117: 303-308.

24.

Khamashta MA et al. The management of thrombosis in the antiphospholipid antibody syndrome. N Eng J Med 1995; 332: 993-997.

25.

Lockshin MD Answers to the antiphospholipid antibody syndrome ? N Eng J Med 332; 15: 1025-1027.

26.

Lockshin MD Pathogenesis of the antiphospholipid antibody syndrome. Lupus 1996; 5: 404-408.

27.

Pierangeli SS et al. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome. Thromb Haemost 1995; 74: 1361-1367.

28.

Brey RL , Levine SR Treatment of neurologic complications of antiphospholipid antibody syndrome . Lupus 1996; 5: 473-476.

29.

Specker C. et al. Cerebral microemboli in patients with antiphospholipid syndrome . Lupus 1997.

30.

Aaslid R. , Markwalder TM , Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 1982; 57: 769-774.

31.

Aaslid R. , Huber P. , Nornes H. Evaluation of cerebrovascular spasm with transcranial Doppler ultrasound. J Neurosurg 1984; 60: 37-41.

32.

Padayachee TS et al. Monitoring middle cerebral artery blood velocity during carotid endarterectomy. Br J Surg 1986; 73: 98-100.

33.

Siebler M. et al. Real-time identification of cerebral microemboli with US feature detection by a Neural Network. Radiology 1994 ; 192: 739-742.

34.

Eicke BM , et al. Serial transcranial Doppler monitoring after transient ischemic attack. J Neuroimag 1996; 6: 174-176.

35.

Babikian V. , Wechsler L. Recent developments in transcranial Doppler sonography. J Neuroimag 1994; 4: 159-163.

36.

Del Sette M. et al. Microembolic signals with serial transcranial doppler monitoring in acute focal ischemic deficit: a local phenomenon? Stroke 1997; 28: 1311-1313.

37.

Babikian VL et al. Cerebral microembolism and early recurrent cerebral or retinal ischemic events. Stroke 1997; 28: 1314-1318.

38.

Georgiadis D. et al. Doppler microembolic signals in children with prosthetic cardiac valves. Stroke 1997 ; 28: 1328-1329.

39.

Siebler M. et al. Cerebral microembolism in symptomatic and asymptomatic high-grade internal carotid artery stenosis. Neurology 1994; 44: 615-618.

40.

Siebler M. et al. Cerebral microembolism and the risk of ischemia in asymptomatic high-grade internal carotid artery stenosis. Stroke 1995; 26: 2184-2186.

41.

Markus HS et al. Intercenter agreement in reading Doppler embolic signals: a multicenter international study. Stroke 1997 ; 28: 1307-1310.